These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21278152)

  • 41. Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study.
    Stuijver DJ; Piantanida E; van Zaane B; Galli L; Romualdi E; Tanda ML; Meijers JC; Büller HR; Gerdes VE; Squizzato A
    Haemophilia; 2014 May; 20(3):326-32. PubMed ID: 24118466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Release of von Willebrand factor by cardiopulmonary bypass, but not by cardioplegia in open heart surgery.
    Valen G; Blombäck M; Sellei P; Lindblom D; Vaage J
    Thromb Res; 1994 Jan; 73(1):21-9. PubMed ID: 8178310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis of Heyde's syndrome by abnormal closure times despite normal von Willebrand's activity.
    D'Souza PM; Blostein MD
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):622-3. PubMed ID: 21760480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Shear stress-associated acquired von Willebrand syndrome in patients with mitral regurgitation.
    Blackshear JL; Wysokinska EM; Safford RE; Thomas CS; Shapiro BP; Ung S; Stark ME; Parikh P; Johns GS; Chen D
    J Thromb Haemost; 2014 Dec; 12(12):1966-74. PubMed ID: 25251907
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease.
    Favaloro EJ; Thom J; Patterson D; Just S; Baccala M; Dixon T; Meiring M; Koutts J; Rowell J; Baker R
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):475-83. PubMed ID: 19584715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.
    Bander J; Elmariah S; Aledort LM; Dlott J; Stelzer P; Halperin JL; Kini AS; Sharma SK
    Thromb Haemost; 2012 Jul; 108(1):86-93. PubMed ID: 22627470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis.
    Panzer S; Badr Eslam R; Schneller A; Kaider A; Koren D; Eichelberger B; Rosenhek R; Budde U; Lang IM
    Thromb Haemost; 2010 Feb; 103(2):408-14. PubMed ID: 20024494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acquired von Willebrand syndrome in adult patients with congenital heart disease.
    Waldow HC; Westhoff-Bleck M; Widera C; Templin C; von Depka M
    Int J Cardiol; 2014 Oct; 176(3):739-45. PubMed ID: 25139318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is hypothermia a benefit? Von Willebrand factor in pediatric cardiopulmonary bypass.
    Bec L; Karolczak MA; Motylewicz B; Rogala E
    J Cardiovasc Surg (Torino); 2006 Apr; 47(2):211-5. PubMed ID: 16572096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acquired von Willebrand Syndrome and Desmopressin Resistance During Venovenous Extracorporeal Membrane Oxygenation in Patients With COVID-19: A Prospective Observational Study.
    Kalbhenn J; Glonnegger H; Büchsel M; Priebe HJ; Zieger B
    Crit Care Med; 2022 Aug; 50(8):1246-1255. PubMed ID: 35234414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perioperative diagnosis and impact of acquired von Willebrand syndrome in infants with congenital heart disease.
    Icheva V; Ebert J; Budde U; Wiegand G; Schober S; Engel J; Kumpf M; Jaschonek K; Neunhoeffer F; Michel J; Schlensak C; Hofbeck M; Magunia H
    Blood; 2023 Jan; 141(1):102-110. PubMed ID: 36054926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of von Willebrand factor in haemostasis and blood loss during and after cardiopulmonary bypass surgery.
    Perrin EJ; Ray MJ; Hawson GA
    Blood Coagul Fibrinolysis; 1995 Oct; 6(7):650-8. PubMed ID: 8562836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease.
    Lison S; Dietrich W; Spannagl M
    Anesth Analg; 2012 Jan; 114(1):73-81. PubMed ID: 22025497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.